Trupanion, Inc. (NASDAQ:TRUP) Receives $36.17 Consensus Target Price from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has been assigned an average rating of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $36.17.

Several analysts have recently issued reports on TRUP shares. Northland Securities increased their price objective on Trupanion from $30.00 to $35.00 and gave the company a “market perform” rating in a research note on Friday, August 9th. William Blair started coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Stifel Nicolaus reiterated a “hold” rating and issued a $30.00 price objective (up from $22.00) on shares of Trupanion in a research note on Friday, August 9th. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Finally, Piper Sandler increased their price objective on Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a research note on Friday, August 9th.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock worth $405,238 over the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Several hedge funds have recently made changes to their positions in TRUP. Quest Partners LLC purchased a new position in shares of Trupanion during the fourth quarter worth about $67,000. Headlands Technologies LLC purchased a new position in shares of Trupanion during the second quarter worth about $162,000. Victory Capital Management Inc. purchased a new position in shares of Trupanion during the fourth quarter worth about $211,000. Blueshift Asset Management LLC purchased a new position in shares of Trupanion during the fourth quarter worth about $220,000. Finally, Oppenheimer Asset Management Inc. purchased a new position in shares of Trupanion during the second quarter worth about $235,000.

Trupanion Stock Down 1.9 %

NASDAQ:TRUP opened at $42.87 on Thursday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock’s fifty day moving average is $37.74 and its two-hundred day moving average is $30.62. Trupanion has a 52 week low of $19.14 and a 52 week high of $48.85. The stock has a market capitalization of $1.81 billion, a price-to-earnings ratio of -66.98 and a beta of 1.74.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.04. The business had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period last year, the firm earned ($0.33) earnings per share. Research analysts anticipate that Trupanion will post -0.37 EPS for the current year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.